Related references
Note: Only part of the references are listed.Long-Term Maintenance With Intramuscular Ketamine for Treatment-Resistant Bipolar II Depression
Cristina Cusin et al.
AMERICAN JOURNAL OF PSYCHIATRY (2012)
Ketamine for Depression: Where Do We Go from Here?
Marije Aan Het Rot et al.
BIOLOGICAL PSYCHIATRY (2012)
Replication of Ketamine's Antidepressant Efficacy in Bipolar Depression: A Randomized Controlled Add-On Trial
Carlos A. Zarate et al.
BIOLOGICAL PSYCHIATRY (2012)
Course of Improvement in Depressive Symptoms to a Single Intravenous Infusion of Ketamine vs Add-on Riluzole: Results from a 4-Week, Double-Blind, Placebo-Controlled Study
Lobna Ibrahim et al.
NEUROPSYCHOPHARMACOLOGY (2012)
Synaptic Dysfunction in Depression: Potential Therapeutic Targets
Ronald S. Duman et al.
SCIENCE (2012)
Dose- and Exposure-Response to Ketamine in Depression
Paul Glue et al.
BIOLOGICAL PSYCHIATRY (2011)
The antidepressant effect of ketamine is not associated with changes in occipital amino acid neurotransmitter content as measured by [1H]-MRS
Gerald W. Valentine et al.
PSYCHIATRY RESEARCH-NEUROIMAGING (2011)
A Randomized Add-on Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Bipolar Depression
Nancy Diazgranados et al.
ARCHIVES OF GENERAL PSYCHIATRY (2010)
Safety and Efficacy of Repeated-Dose Intravenous Ketamine for Treatment-Resistant Depression
Marije aan het Rot et al.
BIOLOGICAL PSYCHIATRY (2010)
Use of oral ketamine in chronic pain management: A review
Maren I. Blonk et al.
EUROPEAN JOURNAL OF PAIN (2010)
Ketamine for the treatment of chronic non-cancer pain
Ingeborg Noppers et al.
EXPERT OPINION ON PHARMACOTHERAPY (2010)
Riluzole for relapse prevention following intravenous ketamine in treatment-resistant depression: a pilot randomized, placebo-controlled continuation trial
Sanjay J. Mathew et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2010)
Oral Ketamine for the Rapid Treatment of Depression and Anxiety in Patients Receiving Hospice Care
Scott A. Irwin et al.
JOURNAL OF PALLIATIVE MEDICINE (2010)
Oral Administration of the NMDA Receptor Antagonist S-Ketamine as Add-On Therapy of Depression: A Case Series
G. Paslakis et al.
PHARMACOPSYCHIATRY (2010)
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression
Carlos A. Zarate et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
Plasma concentration profiles of ketamine and norketamine after administration of various ketamine preparations to healthy Japanese volunteers
Y Yanagihara et al.
BIOPHARMACEUTICS & DRUG DISPOSITION (2003)
Antidepressant effects of ketamine in depressed patients
RM Berman et al.
BIOLOGICAL PSYCHIATRY (2000)
Share Paper
